top of page
MAJOR DISEASE SUBSETS ADDRESSED
ABOUT
ALL ABOUT THE SYMPOSIUM
1. Establish a broad foundation of knowledge in current sarcoma biology, pathology and therapy, and to improve focus and depth of instruction. This will be achieved through both didactic sessions and
case-based / patient-centred discussions.
2. Highlight specific advances in management that have impacted care in recent years, including developments in molecular diagnostic pathology, novel prognostic and predictive biomarkers, the latest techniques to minimise the morbidity of surgery and radiation therapy, and the expanding options of agents for systemic therapy.
3. Emphasize the importance of, address the barriers to, and outline a working approach to
multi-disciplinary care at every stage of patient management.
This conference aims to provide a comprehensive overview of the latest standards of care in managing soft tissue sarcomas, and bone sarcomas.
In addition, we aim to provide a platform for the regional sarcoma community to exchange ideas, engage in discussions and establish collaborations for research and patient care. In an uncommon disease which requires highly specialized care at every point of the disease trajectory, it is hoped that this exchange of knowledge and pooling or resources will go some way towards advancing the standards of sarcoma patient care in the region.
The 5th Singapore Sarcoma Consortium Education and Research Meeting will offer participants a comprehensive update of the multi-disciplinary management of bone sarcoma, and soft tissue sarcomas.
Equally, it aims to bring the local and regional sarcoma community together to establish collaborations for research in this rapidly moving field to accelerate the advancement of sarcoma care in Singapore and the region.
-
Medical Oncologists
-
General Surgeons
-
Orthopaedic Surgeons
-
Radiologists
-
Radiation Oncologists
-
Paediatric Oncologists
-
Pathologists
-
Researchers and Scientists
-
Nursing and Allied Health Professionals
Residents, specialists, nurses and allied health professionals involved and interested in the research and treatment of soft tissue sarcomas, and bony sarcomas.
1. Bone Session (Chondrosarcoma)
2. Soft Tissue Sarcomas: Mesenchymal tumors of intermediate malignant potential
3. Novel therapies in aggressive Soft Tissue Sarcoma
3. Long Term Perspectives of sarcoma treatment
4. Sarcoma Scientific Session
October 7 - 8, 2017
Academia Outram Campus
WHO SHOULD ATTEND
WHY YOU SHOULD ATTEND: BENEFITS
bottom of page